Annual Drug Patent Expirations for SOTALOL+HYDROCHLORIDE Sotalol Hydrochloride is a drug marketed by Altathera Pharms Llc, Apotex, Aurobindo Pharma Usa, Beximco Pharms Usa, Epic Pharma Inc, Impax Pharms, Mylan, Oxford…
The post New patent for Altathera…
New patent for Altathera Pharms drug SOTALOL HYDROCHLORIDE Read Post »
Annual Drug Patent Expirations for SOTALOL+HYDROCHLORIDE Sotalol Hydrochloride is a drug marketed by Altathera Pharms Llc, Apotex, Aurobindo Pharma Usa, Beximco Pharms Usa, Epic Pharma Inc, Impax Pharms, Mylan, Oxford…
The post New patent for Altathera…
New patent for Altathera Pharms drug SOTALOL HYDROCHLORIDE Read Post »
Annual Drug Patent Expirations for NOURESS Nouress is a drug marketed by Baxter Hlthcare Corp and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent for Baxter Hlthcare drug NOURESS appeared first on DrugPa…
Annual Drug Patent Expirations for NOURESS Nouress is a drug marketed by Baxter Hlthcare Corp and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent for Baxter Hlthcare drug NOURESS appeared first on DrugPa…
Annual Drug Patent Expirations for XELJANZ Xeljanz is a drug marketed by Pfizer and Pf Prism Cv and is included in three NDAs. It is available from two suppliers. There…
The post New patent expiration for Pf Prism drug XELJANZ appeared first on DrugPat…
Annual Drug Patent Expirations for XELJANZ+XR Xeljanz Xr is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are five patents…
The post New patent expiration for Pfizer drug XELJANZ XR appeared first on Dr…
New patent expiration for Pfizer drug XELJANZ XR Read Post »
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in six NDAs. It is available from one supplier.…
The post New patent expiration for Otsuka drug ABILIFY appeared first on DrugPatent…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Romania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Romania? Read Post »
This chart shows the pharmaceutical companies with the most patents in Serbia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Serbia? Read Post »
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug T…
New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Get new actionable insights and updates from BiotechBlog
